You searched for "isotretinoin"
Recurrent corneal erosions secondary to isotretinoin use
This article originally appeared in Eye News Dec/Jan 2021 Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations,...
Topical and systemic interventions for the treatment of rosacea
The author provides current statistical information on the incidence of rosacea and ambiguity surrounding the aetiology of the common, yet complex condition. The paper reinforces the importance of providing symptom specific treatments, as well as the key position of aesthetic...Modern laser-assisted acne therapy in practice
Laser and light-based technologies have expanded the therapeutic arsenal for acne, and can improve the skin appearance of inflammatory acne and scarring in a short time, which increases patient compliance and satisfaction. Acne is an inflammatory dermatosis in which pathophysiological...How I Do It - Sebum, science, and the 1726nm laser: Rethinking acne management in a post-antibiotic era
Acne vulgaris remains one of the most prevalent skin conditions worldwide, affecting up to 85% of adolescents and persisting into adulthood for a significant proportion of individuals. Conventional therapies – topical retinoids, oral antibiotics, hormonal agents, and isotretinoin – remain...The future of acne treatment is clear
As acne affects 742 million patients daily, an alarming 48% are unsatisfied with their current acne treatment [1,2]. But the landscape is changing with...How I Do It - Non-ablative laser treatment of surgical and acne-induced scars
Scars tell stories of life – almost everyone has at least one. The disappearance of postoperative scars is important to many of our patients. This is particularly indicated for aesthetically dominant areas such as the face, neck and décolleté, but...How I Do It - Combination treatment of acne vulgaris
Acne vulgaris is a common, globally recognised, chronic condition. According to the Global Burden of Disease (GBD) study, acne vulgaris affects approximately 85% of young adults aged 12-25 years [1]. Acne vulgaris is a disease affecting the pilosebaceous unit (PSU)...
